Sara P. R.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination with Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Evaluation of Ocular Toxicity Mitigation with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate in Recurrent Ovarian Cancer Patients
Data & Insights
Has run more than one trial at 114 of 279 partner sites.
Specializations
Hematologic Malignancies
Investigator Sara Pérez Ramírez leads studies on blood‑derived cancers, including acute and chronic leukemias, lymphomas and plasma‑cell disorders.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Non‑Hodgkin Lymphoma
- Hodgkin Lymphoma
- Myelodysplastic Syndromes
- Myelofibrosis
- Mantle Cell Lymphoma
Focus is on targeted agents, novel immunotherapies and transplant‑based strategies.
Solid Tumor Oncology
Research spans a broad spectrum of solid cancers, with emphasis on advanced disease and biomarker‑driven interventions.
- Non‑Small Cell Lung Cancer
- Small Cell Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Pancreatic Ductal Adenocarcinoma
- Hepatocellular Carcinoma
- Melanoma
- Gastro‑esophageal Adenocarcinoma
- Renal Cell Carcinoma
- Sarcoma
Trials often incorporate genomic profiling, combination regimens and neoadjuvant approaches.
Immuno‑Oncology & Autoimmune Disorders
Investigator Pérez Ramírez explores immune modulation across cancer and systemic autoimmune diseases.
- Immune Checkpoint Inhibition
- CAR‑T Cell Therapy
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Idiopathic Inflammatory Myopathies
- Atopic Dermatitis
- Psoriatic Arthritis
- Multiple Sclerosis
Studies aim to delineate shared pathways and develop therapies that balance anti‑tumor efficacy with autoimmune safety.
Cardiovascular & Pulmonary Comorbidities in Oncology
Focus is on cardio‑pulmonary conditions that impact cancer treatment outcomes.
- Acute Respiratory Distress Syndrome
- Pulmonary Embolism
- Acute Myocardial Infarction
- Heart Failure
- Atherosclerotic Cardiovascular Disease
- Chronic Obstructive Pulmonary Disease
- Interstitial Lung Disease
- COVID‑19
Efforts target risk mitigation, supportive care protocols, and integrated management during oncologic therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.